Beacon Cancer Vaccine Database Summary
- Unrivalled comprehensive & accurate preclinical and clinical Cancer Vaccine drug, trial and commercial data.
- Access to 1,700+ Drugs, 1,600+ Trials, 1,300+ Companies, and 1,100+ Deals in the Cancer Vaccine space
- Market leading ontologies, enabling precise navigation of specific Cancer Vaccines
- Manually curated by Cancer Vaccine scientists, with data updated daily
- Your one stop shop for Cancer Vaccine intelligence data

Why Beacon Cancer Vaccine Database?
How Beacon Cancer Vaccine Database Can Help You?
Give your cancer vaccine drug the best chance of success for a given disease & target, by gaining a comprehensive overview into successful & failed strategies for a antigen class, delivery system, vaccine adjuvant, vaccine type & and more niche technologies using proprietary Cancer vaccine search ontologies to strategically position your drug within niche areas of competition.
Benchmark your preclinical cancer vaccine research with confidence by accessing more preclinical data than anywhere else, spread across curated in vitro, efficacy, toxicity & PK data released for every cancer vaccine program in one place, allowing you to compare every readout against the wider field
Track cancer vaccine developments through to approvals with a market leading curation approach, segmenting clinical readouts into drug dosing, patient data, toxicity & results, with rapid visibility into high performing drugs including overall & partial response, progression free survival & other vital Oncology readouts
Leverage Beacon’s proprietary clinical trial searching filters to run highly targeted combination searches for cancer vaccines and other modalities, leveraging our comprehensive modality tagging within cancer vaccines & other datasets such as checkpoint modulators to laser in on successful strategies & access curated clinical design data points
Optimize your cancer vaccine partnership strategy by identifying new prospect companies or competitors as soon as they enter the field, taking advantage of Beacon’s unique approach to capturing early-stage companies and curated insights on deals & pipelines all in one place
Bulletproof your cancer vaccine investment strategy by confidently communicating your position in the cancer vaccine market to investors, with well benchmarked science, allowing you to stand out in a competitive market using robust data from Beacon.
Beacon helps developers stand out by providing comprehensive insights into targets, diseases, and vaccine design & enhances your ability to attract investors and secure the capital needed to take your cancer vaccine to the next phase.
Beacon Cancer Vaccine Database: The Numbers
Beacon Cancer Vaccine Database: Key Data Segments
Drug Data
Revolutionize your landscape searching for Cancer Vaccines
Utilize >20 search filters to find programs based on disease indication, drug modality, delivery system, vaccine type, vaccine adjuvant and many more.
Trial Data
Optimize your Cancer Vaccine clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the Cancer Vaccine trial landscape based on drug technologies, combination trials, trial locations, trial phase, disease indication and more.
Milestones
A unique Cancer Vaccine development milestone filter and visualization tool.
Track past, present, and future Cancer Vaccine drug development milestones, including drug and trial readouts, asset history, and regulatory announcements.
Company Data
Your centralized location for Cancer Vaccine company intelligence
Identify competitors and business development opportunities, using unique company filters including, company type, HQ locations, operating status & latest funding round, and technologies / diseases targeted in their pipeline.
Deal Data
De-risk your Cancer Vaccine partnership & fundraising projects
Search Cancer Vaccine deals using custom search filters based on drug technologies involved, deal value & upfront payments, deal types to filter M&As, financing & partnership / licensing deals, geographic market, funding type, and many more.
Beacon Cancer Vaccine Database: Drug Modalities
Analyze 1,700+ drugs (preclinical and clinical) and 1,600+ clinical trials (from early to late stage).
Beacon Cancer Vaccine covers therapeutic and prophylactic vaccines which treat and/or prevent oncology indications, including HPV vaccines for high-risk HPV strains. We also cover mRNA vaccines, which have shown an increased development over the last few years.
The following therapeutic classes are included in Beacon Cancer Vaccine:
- Cellular Vaccines (Dendritic Cell Vaccines, Whole Tumor Cell Vaccines, Gene-Modified Tumor Cell Vaccines)
- Viral Vaccines (Replicating and Non-Replicating)
- Bacterial Vaccines
- Yeast Vaccines
- Protein Vaccines
- Peptide Vaccines (Short Peptide and Long Peptide)
- Nucleic Acid-Based Vaccines
- DNA Vaccines
- RNA Vaccines (including mRNA vaccines)
Beacon Cancer Vaccine also includes a host of preclinical data including, cell line and animal model experimental data.
Who is Beacon Cancer Vaccine Database For?
Beacon Cancer Vaccine is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug, trial and commercial data, offering unrivalled insight into the Cancer Vaccine landscape.
Scientific Strategy Leader
Select the right pipeline for your Cancer Vaccine drug development
Research Scientist
Validate new targets & inform your Cancer Vaccine design
Clinical Development
Design optimized Cancer Vaccine clinical trials & benchmark against the competition
Business Development
Uncover new Cancer Vaccine licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging Cancer Vaccine technologies
Translational Development
Confidently take your preclinical Cancer Vaccine into the clinic
Additional Resources
Check out Cancer Vaccine related resources available from Beacon
Our Experts

Isabella Pepe
Lead Research Analyst

Charlie De Lanoy Meijer
Account Manager

Frank Plowden
Account Manager
Hanson Wade Events
Check out the upcoming events from Hanson Wade